Novel imidazolopyrimidines as dual PI3-kinase/mTor inhibitors

被引：0

作者：

Dehnhardt, Christoph ^{[1
]}

Venkatesan, Aranapakam ^{[1
]}

Chen, Zecheng ^{[1
]}

Delos Santos, Efren ^{[1
]}

Santos, Oswaldo ^{[1
]}

Bursavich, Matthew ^{[1
]}

Brooijmans, Natasja ^{[1
]}

Mallon, Robert ^{[1
]}

Hollander, Irwin ^{[1
]}

Feldberg, Larry ^{[1
]}

Lucas, Judy ^{[1
]}

Yu, Ker ^{[1
]}

Ayral-Kaloustian, Semiramis ^{[1
]}

Gibbons, Jay ^{[1
]}

Abraham, Robert ^{[1
]}

Mansour, Tarek ^{[1
]}

机构：

[1] Wyeth Res, Pearl River, NY USA

来源：

CANCER RESEARCH | 2009年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2017

引用

页数：1

共 50 条

[31] This is your PI3-kinase on drugs
不详
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (06): : 481 - 481
[32] Use of genotoxicity endpoints to determine the genotoxic potential of PI3-kinase inhibitors
McComb, Catriona M.
Lynch, Anthony M.
Austin, Caroline A.
MUTAGENESIS, 2010, 25 (06) : 649 - 649
[33] Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase
Staben, Steven T.
Blaquiere, Nicole
Tsui, Vickie
Kolesnikov, Aleksandr
Do, Steven
Bradley, Erin K.
Dotson, Jenna
Goldsmith, Richard
Heffron, Timothy P.
Lesnick, John
Lewis, Cristina
Murray, Jeremy
Nonomiya, Jim
Olivero, Alan G.
Pang, Jodie
Rouge, Lionel
Salphati, Laurent
Wei, BinQing
Wiesmann, Christian
Wu, Ping
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 897 - 901
[34] Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts
Cao, P.
Maira, S-M
Garcia-Echeverria, C.
Hedley, D. W.
BRITISH JOURNAL OF CANCER, 2009, 100 (08) : 1267 - 1276
[35] Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts
P Cao
S-M Maira
C García-Echeverría
D W Hedley
British Journal of Cancer, 2009, 100 : 1267 - 1276
[36] Characterization of novel series of selective PI3Kalpha and PI3Kalpha/mTOR-dual inhibitors
Foster, P.
Rice, K.
Bussenius, J.
Jaeger, C.
Nguyen, L.
Virone-Oddos, A.
Markby, D.
EJC SUPPLEMENTS, 2010, 8 (07): : 53 - 53
[37] A Mechanism for Synergy with Combined mTOR and PI3 Kinase Inhibitors
Yang, Shujie
Xiao, Xue
Meng, Xiangbing
Leslie, Kimberly K.
PLOS ONE, 2011, 6 (10):
[38] Design and synthesis of dual PI3K/mTor inhibitors
Olivero, Alan
Heffron, Timothy
Berry, Leanne
Berry, Megan
Castanedo, Georgette
Chang, Christine
Dotson, Jennafer
Friedman, Lori
Goldsmith, Richard
Lesnick, John
Lewis, Cristina
Mathieu, Simon
Nonomiya, Jim
Pang, Jodie
Peterson, David
Prior, Wei Wei
Salphati, Laurent
Sampath, Deepak
Sutherlin, Daniel
Tsui, Vickie
Ultsch, Mark
Wang, Shumei
Wiesmann, Christian
Wong, Susan
Zhu, Bing-Yan
Chuckowree, Irina
Folkes, Adrian
Shuttleworth, Steve
CANCER RESEARCH, 2009, 69
[39] In vitro and in vivo efficacy of the dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in renal cell carcinoma (RCC)
Cho, Daniel
Cohen, Matthew
Panka, David
Bhatt, Rupal
Signoretti, Sabina
Atkins, Michael
Mier, James
CANCER RESEARCH, 2009, 69
[40] The expanding role of PI3-kinase in bone
Golden, LH
Insogna, KL
BONE, 2004, 34 (01) : 3 - 12

← 1 2 3 4 5 →